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Background Congenital heart defects remain the most common birth defect in humans occurring in almost 1% 
of live births. The majority of the defects are believed to be influenced by both genetic patterning and 
mechanical stimuli such as the shear stress exerted by the blood flow on the developing heart (Hove et al., 
Nature, 2003) The major causes for changes in fluid mechanical environment are changes in the pumping of the 
heart itself. 
The pumping mechanism of the embryonic heart has long been believed to be peristaltic. Recently however 
Forouhar et al. (Science, 2006) proposed dynamic suction as the driving force behind the pumping of hearts prior 
to valve formation. Their suggested mechanism is based on a single activation zone located at the pacemaker 
cells near the inlet of the heart. The contraction of this zone induces waves travelling alongside the heart wall. 
Those passive wall motions are believed to be the cause of the blood flow. 
Our aim is to reveal the mechanism behind the intracardiac blood flow in order to provide more insight in 
cardiac development. 
 
Methods and results Using transmission light microscopy in combination with high speed image recording 
modalities we succeeded in mapping hearts of zebrafish embryo’s, a model frequently used in developmental 
cardiology. 
Trying to understand the underlying players in the cardiac wall motion we compared normal pumping hearts 
with hearts where the pumping efficiency was reduced. To estimate the efficiency of the heart we developed an 
automated algorithm based on pattern recognition to derive the cardiac flow by tracking the motion of aortic 
blood cells in image sequences. 
We used 2,3-butanedione 2-monoxime (BDM) to reduce the pumping efficiency. This drug decouples the 
electrical signal from the muscle. In relative low doses, we noticed a reduction in cardiac output without 
affecting the heart rate.  This finding enable us to investigate the pumping mechanism by comparing the wall 
mechanics of a normal heart (control) with the wall mechanics of a heart with reduced efficiency (after using 
BDM in the same embryo), (figure 1). 
Wall mechanics of embryos treated with BDM showed a group of cells not subjected to any form of motion 
whereas further on the hearttube cells responded normally. This suggest active contraction of muscle cells other 
then the pace maker cells emphasizing the pumping mechanism to be peristaltic instead of dynamic suction. 
To further investigate this we plan to build a computer model of the embryonic heart. Zones actively contracting 
should be characterized as higher pressure zones on the wall. 
 
Figure 1. flow rate and blood velocity in a 30 hpf zebrafish aorta 
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